September 23, 2024
Meet your new patients. You can’t see them, but trillions — maybe quadrillions — of them travel in and out of your practice every day. They’re […]
September 20, 2024
TOPLINE: Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool […]
September 20, 2024
In July, the US Food and Drug Administration (FDA) approved the first blood-based test to screen for colorectal cancer (CRC). The FDA’s approval of Shield (Guardant […]
September 19, 2024
As quality indicators and benchmarks for colonoscopy increase in coming years, gastroenterologists must think about ways to improve performance across the procedure continuum. According to several […]
September 19, 2024
The gold standard for diagnosing gastroesophageal reflux disease (GERD) is impedance-pH monitoring. This test is particularly valuable when endoscopy doesn’t reveal esophagitis yet patients continue to […]
September 19, 2024
Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new […]
September 18, 2024
TOPLINE: Over one third of patients with acute pancreatitis develop exocrine pancreatic insufficiency (EPI) at 12 months, with the key predictors being idiopathic etiology, moderately severe […]
September 12, 2024
Compared with endoscopy, the Baveno VI criteria present a noninvasive and cost-effective method to detect high-risk varices in patients with Child-Pugh A cirrhosis, according to new […]
September 12, 2024
TOPLINE: A gastrointestinal (GI)-targeted bitter hop extract reduced hunger and food cravings, as well as post-fast ad libitum energy intake, among women undergoing a 24-hour, water-only […]